Natixis’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,888
Closed -$516K 958
2024
Q2
$516K Sell
1,888
-98
-5% -$26.8K ﹤0.01% 599
2024
Q1
$687K Buy
1,986
+65
+3% +$22.5K ﹤0.01% 564
2023
Q4
$620K Buy
1,921
+540
+39% +$174K ﹤0.01% 571
2023
Q3
$495K Buy
1,381
+98
+8% +$35.1K ﹤0.01% 593
2023
Q2
$486K Buy
1,283
+587
+84% +$223K ﹤0.01% 631
2023
Q1
$333K Sell
696
-299
-30% -$143K ﹤0.01% 669
2022
Q4
$418K Sell
995
-420
-30% -$177K ﹤0.01% 681
2022
Q3
$591K Buy
1,415
+379
+37% +$158K ﹤0.01% 819
2022
Q2
$513K Sell
1,036
-52,404
-98% -$25.9M ﹤0.01% 889
2022
Q1
$30.1M Buy
53,440
+36,886
+223% +$20.8M 0.1% 188
2021
Q4
$12.5M Buy
16,554
+15,981
+2,789% +$12.1M 0.04% 335
2021
Q3
$427K Buy
573
+70
+14% +$52.2K ﹤0.01% 1037
2021
Q2
$324K Sell
503
-144,225
-100% -$92.9M ﹤0.01% 778
2021
Q1
$82.7M Buy
144,728
+92,340
+176% +$52.7M 0.27% 81
2020
Q4
$30.5M Buy
+52,388
New +$30.5M 0.11% 184
2020
Q3
Sell
-679
Closed -$307K 766
2020
Q2
$307K Sell
679
-21,517
-97% -$9.73M ﹤0.01% 662
2020
Q1
$7.78M Buy
22,196
+6,177
+39% +$2.17M 0.06% 221
2019
Q4
$5.92M Sell
16,019
-22,354
-58% -$8.26M 0.04% 374
2019
Q3
$12.8M Buy
+38,373
New +$12.8M 0.08% 224
2019
Q2
Sell
-93,823
Closed -$28.5M 763
2019
Q1
$28.5M Buy
+93,823
New +$28.5M 0.18% 126
2018
Q3
Sell
-6,774
Closed -$1.96M 822
2018
Q2
$1.96M Sell
6,774
-5,221
-44% -$1.51M 0.01% 528
2018
Q1
$3M Buy
11,995
+4,357
+57% +$1.09M 0.02% 454
2017
Q4
$1.82M Buy
7,638
+1,249
+20% +$298K 0.01% 427
2017
Q3
$1.42M Buy
+6,389
New +$1.42M 0.01% 470
2017
Q2
Sell
-4,028
Closed -$803K 825
2017
Q1
$803K Buy
+4,028
New +$803K 0.01% 425